Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

June 01, 1985; Volume 233,Issue 3
  • You have access
    Role of dopamine in the neurotoxic effects of methamphetamine.
    C J Schmidt, J K Ritter, P K Sonsalla, G R Hanson and J W Gibb
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 539-544;
  • You have access
    Chronic stress, aging and morphine analgesia: chronic stress affects the reactivity to morphine in young mature but not old rats.
    M N Girardot and F A Holloway
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 545-553;
  • You have access
    Behavioral studies with anxiolytic drugs. I. Interactions of the benzodiazepine antagonist Ro 15-1788 with chlordiazepoxide, pentobarbital and ethanol.
    J E Barrett, L S Brady and J M Witkin
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 554-559;
  • You have access
    Differences in responsiveness of intrapulmonary artery and vein to arachidonic acid: mechanism of arterial relaxation involves cyclic guanosine 3':5'-monophosphate and cyclic adenosine 3':5'-monophosphate.
    L J Ignarro, R G Harbison, K S Wood, M S Wolin, D B McNamara, A L Hyman and P J Kadowitz
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 560-569;
  • You have access
    Sympathetic denervation does not alter the density or properties of alpha-1 adrenergic receptors in rat vas deferens.
    P W Abel, R D Johnson, T J Martin and K P Minneman
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 570-577;
  • You have access
    Modification of sympathetic neuronal function in the rat tail artery by dietary lipid treatment.
    R L Panek, W R Dixon and C O Rutledge
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 578-583;
  • You have access
    Inheritance of liver N-acetyltransferase activity in the rapid and slow acetylator inbred hamster.
    D W Hein, W G Kirlin, R J Ferguson and W W Weber
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 584-587;
  • You have access
    Alcohol effects on luteinizing hormone and testosterone in male macaque monkeys.
    N K Mello, J H Mendelson, M P Bree, J Ellingboe and A S Skupny
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 588-596;
  • You have access
    Sigma opioid receptor: characterization and co-identity with the phencyclidine receptor.
    L G Mendelsohn, V Kalra, B G Johnson and G A Kerchner
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 597-602;
  • You have access
    Solubilization and characterization of putative alpha-2 adrenergic isoceptors from the human platelet and the rat cerebral cortex.
    R S Kawahara and D B Bylund
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 603-610;
  • You have access
    Potent enhancement of [3H]nitrendipine binding in rat cerebral cortical and cardiac homogenates: a putative mechanism for the action of MDL 12,330A.
    H R Lee, J A Jaros, W R Roeske, N L Wiech, R Ursillo and H I Yamamura
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 611-616;
  • You have access
    Effects of isoproterenol on histamine release induced from monodispersed guinea-pig lung cells by different secretagogues.
    B J Undem, F M Graziano and C K Buckner
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 617-622;
  • You have access
    Adenosine receptors on canine parietal cells modulate gastric acid secretion to histamine.
    J G Gerber, A S Nies and N A Payne
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 623-627;
  • You have access
    Relaxant and contractile responses to prostaglandins in premature, newborn and adult baboon cerebral arteries.
    S Hayashi, M K Park and T J Kuehl
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 628-635;
  • You have access
    Calcium entry blockade by nitrendipine and alpha adrenergic responsiveness in vivo: comparison with noncalcium entry blocker vasodilators in absence and presence of phenoxybenzamine pretreatment.
    R Pedrinelli and R C Tarazi
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 636-642;
  • You have access
    Calcium entry blockade by nitrendipine and alpha adrenergic responsiveness in vivo: comparison of systemic vs. local effects.
    R Pedrinelli and R C Tarazi
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 643-649;
  • You have access
    Glucocorticoid modulation of prostacyclin production in cultured bovine pulmonary endothelial cells.
    D J Crutchley, U S Ryan and J W Ryan
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 650-655;
  • You have access
    Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics.
    E Meller, K Bohmaker, M Goldstein and A J Friedhoff
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 656-662;
  • You have access
    GABAergic inhibition of hypertonic saline-induced vasopressin-dependent hypertension.
    T J Brennan and J R Haywood
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 663-671;
  • You have access
    Hemodynamic roles of thromboxane A2 and prostaglandin E2 in glomerulonephritis.
    J E Stork and M J Dunn
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 672-678;
  • You have access
    Blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation of rabbit aorta by certain ferrous hemoproteins.
    W Martin, G M Villani, D Jothianandan and R F Furchgott
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 679-685;
  • You have access
    Characterization of [3H]leukotriene D4 binding sites in guinea-pig ventricular myocardium.
    G K Hogaboom, S Mong, J M Stadel and S T Crooke
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 686-693;
  • You have access
    Electroneutral transport of organic cations in canine renal brush border membrane vesicles (BBMV).
    P P Sokol, P D Holohan and C R Ross
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 694-699;
  • You have access
    Permissive role of prostaglandins in the action of bradykinin on the pancreas of anesthetized dogs.
    K Iwatsuki, T Homma and K U Malik
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 700-706;
  • You have access
    Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    J H Lee and E E el-Fakahany
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 707-714;
  • You have access
    Aluminum and gallium arrest formation of cerebrospinal fluid by the mechanism of OH- depletion.
    B P Vogh, D R Godman and T H Maren
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 715-721;
  • You have access
    Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
    L L Werling, G D Zarr, S R Brown and B M Cox
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 722-728;
  • You have access
    Alpha-1 adrenergic control of the venous circulation in intact dogs.
    C Appleton, M Olajos, E Morkin and S Goldman
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 729-734;
  • You have access
    In vivo receptor binding of opioid drugs at the mu site.
    J S Rosenbaum, N H Holford and W Sadée
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 735-740;
  • You have access
    Mechanism of oxmetidine (SK&F 92994) cytotoxicity in isolated rat hepatocytes.
    G F Rush, M Ripple and R Chenery
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 741-746;
  • You have access
    Pharmacological differences between the D-2 autoreceptor and the D-1 dopamine receptor in rabbit retina.
    M L Dubocovich and N Weiner
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 747-754;
  • You have access
    Cardiovascular effects of spinal cord substance P: studies with a stable receptor agonist.
    J R Keeler, C G Charlton and C J Helke
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 755-760;
  • You have access
    5-Hydroxytryptamine receptor in isolated rabbit aorta: characterization with tryptamine analogs.
    B M Clancy and S Maayani
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 761-769;
  • You have access
    Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state.
    M W Teunissen, L G De Leede, J K Boeijinga and D D Breimer
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 770-775;
  • You have access
    Transport of p-aminohippurate, tetraethylammonium and D-glucose in renal brush border membranes from rats with acute renal failure.
    R Hori, M Takano, T Okano and K Inui
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 776-781;
  • You have access
    Inhibitory effects of norepinephrine, methoxamine and phenylephrine on renin release from rat kidney cortical slices.
    Y Matsumura, N Miyawaki, Y Sasaki and S Morimoto
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 782-787;
  • You have access
    Disposition of enalapril in the perfused rat intestine-liver preparation: absorption, metabolism and first-pass effect.
    K S Pang, W F Cherry and E H Ulm
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 788-795;
  • You have access
    Adrenergic and possible nonadrenergic sources of adenosine 5'-triphosphate release from nerve varicosities isolated from ileal myenteric plexus.
    M Al-Humayyd and T D White
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 796-800;
  • You have access
    Effects of tertatolol on post- and prejunctional beta adrenoceptors.
    T J Verbeuren, G Laekeman, B B Majchrowicz, F H Jordaens, L L Zonnekeyn and A G Herman
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 801-809;
  • You have access
    Possible inhibitory role of endogenous gamma-aminobutyric acid in the nonnicotinic functions of the dog cardiac sympathetic ganglia.
    K Kushiku and T Furukawa
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 810-815;
  • You have access
    A comparison of two radioimmunoassays for 7-hydroxychlorpromazine: rabbit polyclonal antibodies vs. mouse monoclonal antibodies.
    P K Yeung, G McKay, I A Ramshaw, J W Hubbard and K K Midha
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 816-822;
  • You have access
    Renal tubular action of prostaglandin E2 on water and electrolyte excretion in the nonanesthetized chicken.
    K Besseghir
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 823-829;
  • You have access
    Do D 600 and diltiazem interact with serotonin receptors in rabbit vascular tissues?
    M Ohashi, R Kanai and I Takayanagi
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 830-835;
  • You have access
    CM 40907: a structurally novel anticonvulsant in mice, rats and baboons.
    J P Chambon, J Brochard, A Hallot, M Heaulme, R Brodin, R Roncucci and K Biziere
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 836-844;
  • You have access
    Effects of nifedipine on coronary vasculature in canine models of dynamic and fixed coronary stenoses.
    M Yokoyama, S Sakamoto, A Kusui, H Akita, K Maekawa and H Fukuzaki
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 845-852;
  • You have access
    Neurotoxic and antihypertensive effects of phenytoin in turkeys.
    C F Simpson and W J Taylor
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 853-856;
  • You have access
    Immunological studies on the mechanism of halothane-induced hepatotoxicity: immunohistochemical evidence of trifluoroacetylated hepatocytes.
    H Satoh, Y Fukuda, D K Anderson, V J Ferrans, J R Gillette and L R Pohl
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 857-862;
  • You have access
    Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
    R M Eisenberg
    Journal of Pharmacology and Experimental Therapeutics June 1985, 233 (3) 863-869;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 233, Issue 3
1 Jun 1985
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Smoking Could Worsen COVID-19 Outcome
  • KBP-042 as Adjunct Therapy to Metformin
  • SARS-CoV-2 Drug Discovery
  • Potential Clinical Uses of CBG
  • Nose-to-Brain Delivery
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics